385 related articles for article (PubMed ID: 26529014)
21. A randomized, double-blind, placebo-controlled trial of onabotulinumtoxin A trigger point injections for myofascial pelvic pain.
Dessie SG; Von Bargen E; Hacker MR; Haviland MJ; Elkadry E
Am J Obstet Gynecol; 2019 Nov; 221(5):517.e1-517.e9. PubMed ID: 31254522
[TBL] [Abstract][Full Text] [Related]
22. Botulinum toxin A for prophylactic treatment of migraine and tension headaches in adults: a meta-analysis.
Jackson JL; Kuriyama A; Hayashino Y
JAMA; 2012 Apr; 307(16):1736-45. PubMed ID: 22535858
[TBL] [Abstract][Full Text] [Related]
23. Osteopenic consequences of botulinum toxin injections in the masticatory muscles: a pilot study.
Raphael KG; Tadinada A; Bradshaw JM; Janal MN; Sirois DA; Chan KC; Lurie AG
J Oral Rehabil; 2014 Aug; 41(8):555-63. PubMed ID: 24836732
[TBL] [Abstract][Full Text] [Related]
24. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke.
Brashear A; Gordon MF; Elovic E; Kassicieh VD; Marciniak C; Do M; Lee CH; Jenkins S; Turkel C;
N Engl J Med; 2002 Aug; 347(6):395-400. PubMed ID: 12167681
[TBL] [Abstract][Full Text] [Related]
25. Botulinum type A toxin complex for the relief of upper back myofascial pain syndrome: how do fixed-location injections compare with trigger point-focused injections?
Benecke R; Heinze A; Reichel G; Hefter H; Göbel H;
Pain Med; 2011 Nov; 12(11):1607-14. PubMed ID: 21692970
[TBL] [Abstract][Full Text] [Related]
26. Botulinum toxin type A for the treatment of glabellar lines in Chinese: a double-blind, randomized, placebo-controlled study.
Wu Y; Zhao G; Li H; Zheng Z; Zhong S; Yang Z; Feng Z; Yang Q; Zhu X
Dermatol Surg; 2010; 36(1):102-8. PubMed ID: 20002637
[TBL] [Abstract][Full Text] [Related]
27. Prior Botulinum Toxin Treatment Does Not Impact Efficacy or Safety in Clinical Trials: Analysis of DaxibotulinumtoxinA for Injection in the SAKURA Program.
Cohen JL; Green LJ; Beer KR; Liu Y; Gallagher CJ
Dermatol Surg; 2021 Apr; 47(4):511-515. PubMed ID: 33587381
[TBL] [Abstract][Full Text] [Related]
28. Botulinum toxin type A for the treatment of migraine.
Aurora S
Expert Opin Pharmacother; 2006 Jun; 7(8):1085-95. PubMed ID: 16722818
[TBL] [Abstract][Full Text] [Related]
29. [Analysis on rules of acupoint compatibility and application characteristics in acupuncture treatment of migraine based on complex network technique].
Han P; Wen J; Wu HH; Wang RQ; Shi J; Xing HJ; Zhang XQ; Jia CS; Li XF
Zhen Ci Yan Jiu; 2022 Feb; 47(2):171-6. PubMed ID: 35218629
[TBL] [Abstract][Full Text] [Related]
30. Botulinum toxin injection in the management of chronic migraine: the Saudi experience with a proposal for a new protocol.
Algahtani H; Shirah B; Sukkar G; Bukhari H; Meftah I; Alhazmi A; Alshareef A; Algethami A; Alshanqiti A; Andeejani M
Acta Neurol Belg; 2021 Dec; 121(6):1783-1787. PubMed ID: 33058053
[TBL] [Abstract][Full Text] [Related]
31. Botulinum toxin a versus placebo for refractory detrusor overactivity in women: a randomised blinded placebo-controlled trial of 240 women (the RELAX study).
Tincello DG; Kenyon S; Abrams KR; Mayne C; Toozs-Hobson P; Taylor D; Slack M
Eur Urol; 2012 Sep; 62(3):507-14. PubMed ID: 22236796
[TBL] [Abstract][Full Text] [Related]
32. Predictors of response to botulinum toxin type A (BoNTA) in chronic daily headache.
Mathew NT; Kailasam J; Meadors L
Headache; 2008 Feb; 48(2):194-200. PubMed ID: 17868356
[TBL] [Abstract][Full Text] [Related]
33. Clinical trial to evaluate the efficacy of botulinum toxin type A injection for reducing scars in patients with forehead laceration: A double-blinded, randomized controlled study.
Kim SH; Lee SJ; Lee JW; Jeong HS; Suh IS
Medicine (Baltimore); 2019 Aug; 98(34):e16952. PubMed ID: 31441893
[TBL] [Abstract][Full Text] [Related]
34. OnabotulinumtoxinA for treatment of chronic migraine: pooled analyses of the 56-week PREEMPT clinical program.
Aurora SK; Winner P; Freeman MC; Spierings EL; Heiring JO; DeGryse RE; VanDenburgh AM; Nolan ME; Turkel CC
Headache; 2011 Oct; 51(9):1358-73. PubMed ID: 21883197
[TBL] [Abstract][Full Text] [Related]
35. Method of injection of onabotulinumtoxinA for chronic migraine: a safe, well-tolerated, and effective treatment paradigm based on the PREEMPT clinical program.
Blumenfeld A; Silberstein SD; Dodick DW; Aurora SK; Turkel CC; Binder WJ
Headache; 2010 Oct; 50(9):1406-18. PubMed ID: 20958294
[TBL] [Abstract][Full Text] [Related]
36. [Botulinum toxin injections for chronic migraine in adolescents - an early therapeutic option in the transition from neuropaediatrics to neurology].
Bernhard MK; Bertsche A; Syrbe S; Weise S; Merkenschlager A
Fortschr Neurol Psychiatr; 2014 Jan; 82(1):39-42. PubMed ID: 24446117
[TBL] [Abstract][Full Text] [Related]
37. Botulinum toxin type A (BOTOX) for treatment of migraine.
Binder WJ; Brin MF; Blitzer A; Pogoda JM
Dis Mon; 2002 May; 48(5):323-35. PubMed ID: 12195263
[TBL] [Abstract][Full Text] [Related]
38. A prospective, multicentre, randomized, double-blind, placebo-controlled trial of onabotulinumtoxinA to treat plantarflexor/invertor overactivity after stroke.
Dunne JW; Gracies JM; Hayes M; Zeman B; Singer BJ;
Clin Rehabil; 2012 Sep; 26(9):787-97. PubMed ID: 22308557
[TBL] [Abstract][Full Text] [Related]
39. Botulinum toxins for the prevention of migraine in adults.
Herd CP; Tomlinson CL; Rick C; Scotton WJ; Edwards J; Ives N; Clarke CE; Sinclair A
Cochrane Database Syst Rev; 2018 Jun; 6(6):CD011616. PubMed ID: 29939406
[TBL] [Abstract][Full Text] [Related]
40. Overview of DaxibotulinumtoxinA for Injection: A Novel Formulation of Botulinum Toxin Type A.
Solish N; Carruthers J; Kaufman J; Rubio RG; Gross TM; Gallagher CJ
Drugs; 2021 Dec; 81(18):2091-2101. PubMed ID: 34787840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
